Proper Pressure and Duration of Sustained Lung Inflation in Preterm Infants
NCT ID: NCT02846597
Last Updated: 2018-04-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
100 participants
INTERVENTIONAL
2013-03-31
2016-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sustained Lung Inflation in Preterm Infants
NCT03518762
Ventilatory Management of the Preterm Neonate in the Delivery Room
NCT01255826
Sustained Lung Inflation in the Delivery Room in Preterm Infants at High Risk of Respiratory Distress Syndrome
NCT01440868
Vojta Reflex Versus Lung Squeezing Technique in Respiratory Distress Preterm Neonate
NCT06992492
Effect of Implementing Evidence Based Practices on Prevention of Associated Nasal Pressure Injuries Among Preterm Neonates With Non-Invasive Respiratory Support
NCT06642285
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Preterm infants born equal to or less than 32 weeks gestation with respiratory distress syndrome will be included in the study.
We aim to study the proper pressure and duration of sustained lung inflation in the delivery room.
Preterm infants will be divided into 5 groups:
1. Group 1 (Control group). In this group preterm infants will not be treated with sustained lung inflation and in stead will receive regular respiratory care
2. Group 2 (High pressure for long duration group). Preterm infants in this group will be treated with sustained lung inflation at pressure of 20 cm H2O for 20 seconds
3. Group 3 (High pressure for short duration group). Preterm infants in this group will be treated with sustained lung inflation at pressure of 20 cm H2O for 10 seconds.
4. Group 4 (Low pressure for long duration group). Preterm infants in this group will be treated with sustained lung inflation at pressure of 15 cm H2O for 20 seconds.
5. Group 5 (Low pressure for short duration group). Preterm infants in this group will be treated with sustained lung inflation at pressure of 15 cm H2O for 10 seconds
Sustained lung inflation will be delivered using the T - piece ventilator (Neopuff infant resuscitator; Fisher \& Paykel, Auckland, New Zealand ).
All preterm infants with respiratory distress will follow the following steps for neonatal resuscitation
1. All infants will receive initial care including providing warmth, clearing the airway, and drying and stimulating the infant.
2. After the initial steps, pulse oximetry will be initiated to determine oxygen saturation and to guide the required FIO2.
3. Infants in the intervention groups will receive a single single maneuver of sustained lung inflation with the first breath according to the study group.
4. Continuous positive airway pressure at a pressure of 5 cm H2O and FIO2 of 30% will be delivered to infants in the control group immediately after initial steps of resuscitation and to all infants in the intervention groups after the single maneuver of sustained lung inflation.
5. Positive pressure ventilation will be provided uring the T-piece resuscitator if the infant has an inadequate respiratory effort or a heart rate \<100 beats per minute at a rate of 40 to 60 times per minute for 30 seconds, after which the heart rate is measured.
6. Oxygen therapy will be titrated to keep a pre-ductal saturation between 90-95%.
7. Endotracheal intubation will be provided if positive pressure ventilation is ineffective, prolonged apnea, or chest compression is required.
8. Chest compression will be required if the infant's heart rate remains \<60 bpm despite adequate ventilation for 30 seconds.
9. Surfactant will be administered to preterm infants requiring a fraction of inspired oxygen of 40 percent or higher to maintain oxygen saturation above 90 percent or remain apneic.
10. Mechanical ventilation will be initiated for preterm infants with respiratory acidosis documented by an arterial pH \<7.2 and PaCO2 \>60 to 65 mmHg, hypoxia documented by an arterial PaO2 \<50 mmHg despite FiO2 exceeds 40 percent on nasal continuous positive airway pressure, or severe apnea.
The primary outcome of the study will be the need for endotracheal intubation in the delivery room.
Secondary outcomes include the need for surfactant therapy, the need for endotracheal intubation and mechanical ventilation within 72 hours of birth, the duration of mechanical ventilation and oxygen support, development of air leak syndromes, length of hospital stay, bronchopulmonary dysplasia, necrotising enterocolitis, intraventricular haemorrhage, retinopathy of prematurity, and neonatal mortality before hospital discharge,.
Broncho alveolar lavage will be performed to endotracheally intubated infants enrolled in this study to measure the level of IL-10 as a lung inflammatory marker immediately after birth (basal) then 12 hours after birth (follow up).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Infants in this group will not receive sustained lung inflation in the delivery room and will be put immediately on CPAP at a pressure of 5 cm H2O.
No interventions assigned to this group
High pressure for long duration
Infants in this group will receive sustained lung inflation in the delivery room at a pressure of 20 cm H2O for a duration of 20 second for a single intervention followed by CPAP at a pressure of 5 cm H2O.
Sustained lung inflation in preterms (SLI).
Providing a positive pulmonary ventilation with an opening lung pressure for the first breath of preterm infant for a sustained period of time
High pressure for short duration
Infants in this group will receive sustained lung inflation in the delivery room at a pressure of 20 cm H2O for a duration of 10 second for a single intervention followed by CPAP at a pressure of 5 cm H2O.
Sustained lung inflation in preterms (SLI).
Providing a positive pulmonary ventilation with an opening lung pressure for the first breath of preterm infant for a sustained period of time
Low pressure for long duration
Infants in this group will receive sustained lung inflation in the delivery room at a pressure of 15 cm H2O for a duration of 20 second for a single intervention followed by CPAP at a pressure of 5 cm H2O.
Sustained lung inflation in preterms (SLI).
Providing a positive pulmonary ventilation with an opening lung pressure for the first breath of preterm infant for a sustained period of time
Low pressure for short duration
Infants in this group will receive sustained lung inflation in the delivery room at a pressure of 15 cm H2O for a duration of 10 second for a single intervention followed by CPAP at a pressure of 5 cm H2O.
Sustained lung inflation in preterms (SLI).
Providing a positive pulmonary ventilation with an opening lung pressure for the first breath of preterm infant for a sustained period of time
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sustained lung inflation in preterms (SLI).
Providing a positive pulmonary ventilation with an opening lung pressure for the first breath of preterm infant for a sustained period of time
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. \- Presence of major congenital malformation (dysmorphic features or anomalies incompatible with life) .
1 Day
1 Day
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mansoura University Children Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nehad Nasef
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mansoura University Children Hospital
Al Mansurah, El Dakahlya, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NICU MUCH 2016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.